Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVAC
4701
DELISTED
Intevac Inc
IVAC
| $26.8K | ﹤0.01% |
7,879
-788
| -9% | -$2.87K |
|
4702
Brookfield Infrastructure Partners
BIP
$19.6B
| $26.1K | ﹤0.01% |
746
+140
| +23% | +$4.4K |
|
4703
SB Financial Group
SBFG
$163M
| $26.1K | ﹤0.01% |
1,271
+972
| +325% | +$15.9K |
|
4704
Cato Corp
CATO
$65.7M
| $25.7K | ﹤0.01% |
5,155
+2,922
| +131% | +$14.4K |
|
4705
Precision BioSciences
DTIL
$178M
| $25.7K | ﹤0.01% |
2,870
| – | – |
|
4706
BiomX
PHGE
$1.97M
| $25.5K | ﹤0.01% |
1,316
| – | – |
|
|
AFMD
4707
DELISTED
Affimed
AFMD
| $25.3K | ﹤0.01% |
7,516
| – | – |
|
|
FLG
4708
PUT
Flagstar Bank National Association
FLG
$5.87B
| $25.2K | ﹤0.01% |
+2,244
| New | +$23.9K |
|
4709
Eos Energy Enterprises
EOSE
$1.14B
| $25K | ﹤0.01% |
8,414
-1,304
| -13% | -$2.76K |
|
|
HMNF
4710
DELISTED
HMN Financial Inc
HMNF
| $24.8K | ﹤0.01% |
+890
| New | +$22.8K |
|
4711
Civeo
CVEO
$356M
| $24.7K | ﹤0.01% |
902
-1,207
| -57% | -$31.9K |
|
4712
Immuneering
IMRX
$262M
| $24.7K | ﹤0.01% |
9,924
-251
| -2% | -$365 |
|
4713
Companhia Siderúrgica Nacional
SID
$1.37B
| $24.7K | ﹤0.01% |
10,328
+4,688
| +83% | +$10.3K |
|
4714
FT Vest US Equity Buffer ETF November
FNOV
$1.19B
| $24.6K | ﹤0.01% |
+522
| New | +$24.2K |
|
|
WMPN
4715
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $24.5K | ﹤0.01% |
+1,999
| New | +$23.6K |
|
|
BRFS
4716
DELISTED
BRF SA
BRFS
| $24.5K | ﹤0.01% |
+5,603
| New | +$23.7K |
|
|
FONR
4717
DELISTED
Fonar
FONR
| $24.4K | ﹤0.01% |
+1,509
| New | +$25.8K |
|
4718
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$201M
| $24.2K | ﹤0.01% |
+657
| New | +$23.9K |
|
4719
Better Home & Finance Holding
BETR
$391M
| $24K | ﹤0.01% |
1,350
-1
| -0.1% | -$21 |
|
4720
Roadzen
RDZN
$98.1M
| $23.7K | ﹤0.01% |
19,911
+14,627
| +277% | +$25.3K |
|
4721
Aclaris Therapeutics
ACRS
$715M
| $23.5K | ﹤0.01% |
20,393
-19,852
| -49% | -$24.3K |
|
|
AISP
4722
Airship AI Holdings
AISP
$58.9M
| $22.7K | ﹤0.01% |
9,881
+8,834
| +844% | +$28.6K |
|
4723
Red Cat Holdings
RCAT
$1.03B
| $22.3K | ﹤0.01% |
+8,790
| New | +$20.9K |
|
4724
First Guaranty Bancshares
FGBI
$155M
| $22.2K | ﹤0.01% |
+2,089
| New | +$21.2K |
|
4725
Veritone
VERI
$92.9M
| $21.9K | ﹤0.01% |
6,113
+6,112
| +611,200% | +$18.7K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.